跳至主要内容
临床试验/NCT05112614
NCT05112614招募中不适用

Role of Gut Microbiome in Cancer Therapy

Mayo Clinic3 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2019年9月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
3,000
试验地点
3
主要终点
Associations between microbial community abundances and clinical outcomes

研究概览

简要总结

This study examines how gut microbiome can affect cancer therapy in cancer patients undergoing cancer therapy or stem cell transplant. The human microbiome affects the way some cancer drugs are metabolized in the human body. Information from this study may help doctors improve the way cancer treatment is delivered, and increase its effectiveness and success.

详细描述

PRIMARY OBJECTIVE:

I. To correlate gut microbiome with specific cancer diagnoses and the clinical response (efficacy), and adverse effects of cancer therapy (single or multiple) and stem cell transplant.

OUTLINE:

Patients undergo collection of blood and stool samples and have their medical records reviewed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-99
  • Diagnosis of cancer and undergoing cancer therapy or scheduled to start cancer therapy or undergoing stem cell transplant for any hematological condition

排除标准

  • Unable to provide informed consent
  • Vulnerable adults

研究组 & 干预措施

Observational (biospecimen collection, medical record review)

Patients undergo collection of blood and stool samples and have their medical records reviewed.

干预措施: Biospecimen Collection (Procedure)

Observational (biospecimen collection, medical record review)

Patients undergo collection of blood and stool samples and have their medical records reviewed.

干预措施: Electronic Health Record Review (Other)

结局指标

主要结局

Associations between microbial community abundances and clinical outcomes

时间窗: Through study completion, average of 1 year

Will use a linear multivariate regression model specifically developed for microbiome data (MaAsLin, Multivariate microbial Association by Linear models.

Gut microbiome associations with cancer diagnoses

时间窗: Through study completion, average of 1 year

Will be done using Shogun pipeline for metagenomics data followed by analysis using Quantitative Insights Into Microbial Ecology (QIIME) 2.0.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验